For people whose autumn agenda includes getting vaccinated against respiratory diseases — covid, flu, and, for some, RSV — this year may be surprisingly routine. Following several confusing months this summer when federal officials announced and then retreated from changes to covid vaccine recommendations, the Centers for Disease Control and Prevention on Oct. 6 announced…
Family premiums for employer-sponsored health insurance reached an average of $26,993 this year, KFF’s annual benchmark health benefits survey of large and smaller employers finds. On average, workers contribute $6,850 annually to the cost of family coverage, with employers paying the rest.
This policy explainer describes what Individual Coverage Health Reimbursement Arrangements (ICHRAs) are and how do they differ from typical employer-sponsored health care plans.
This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, worker contributions, cost-sharing provisions, offer rates, and more. This year’s report also looks at how employers are approaching coverage of GLP-1 drugs for weight loss, including their concerns about utilization and cost.
Agentic AI company Hyro has now raised a total of $95 million. Its agents, which automate call center workflows, are used by health systems including Intermountain Healthcare, Bon Secours Mercy Health, Hackensack Meridian Health, Baptist Health and Sutter Health. The post Hyro Snags $45M for Its Conversational AI Agents appeared first on MedCity News.
The FDA’s new CNPV pilot program awards nine companies with expedited review processes
The AMA has launched a new Center for Digital Health and AI to ensure physicians are actively involved in shaping how emerging technologies are integrated into healthcare. The post AMA Unveils Center for Digital Health and AI to Elevate Physician Voice in Tech appeared first on MedCity News.
Health system’s AI partner Hyro announces $45 million in new funding led by Healthier Capital, with participation from Norwest and Define Ventures
Non-binding offers for Galapagos’s cell therapies assets came mostly from financial investors, and none offered sufficient terms or financing to support the business, the company said. Galapagos’s exit from cell therapy work will lead to site closures in Europe, China, and the U.S. The post Galapagos to Wind Down Cell Therapy Business After Search for…
That is the title of a paper published today in Future Oncology with co-authors Erin Mulvey, Kyi-Sin Than, Sanjana Muthukrishnan, Alex Mutebi, Anindit Chhibber, Anthony Wang, Abualbishr Alshreef, Diala Harb, Victor Gonzalez, Sarah Quinlan, Vardhaman Patel and Patrick Connor Johnson. The study was conducted in collaboration with the Lymphoma Research Foundation. The abstract is below:…
